Singapore-based well being know-how firm MiyaHealth has acquired an undisclosed sum of funding from HealthXCapital, Central Capital Ventura, and SEEDS Capital.
This comes on prime of the $4.8 million it raised in a pre-Sequence A spherical earlier this 12 months.
Based in 2019, the startup affords two know-how platforms: MiyaPatient, a navigation platform that helps sufferers handle their persistent sickness, and MiyaPayor, which mixes AI-powered claims processing and predictive analytics. It’s arising with a 3rd providing, MiyaProvider, which is meant to reinforce sufferers’ expertise in hospitals and clinics.
At current, over 3,000 medical suppliers and 12,000 physicians have been utilizing these platforms.
WHAT IT’S FOR
The corporate mentioned the extra funding will assist increase its product improvement, hiring, and enlargement plans. Particularly, it can help in its efforts to deploy MiyaPatient for the primary time in Europe and the MiyaPayor and MiyaProvider platforms in Indonesia and the Philippines.
THE LARGER TREND
Alongside this announcement, MiyaHealth additionally disclosed that it’s making ready to launch a Sequence A fundraiser “within the subsequent six months,” the proceeds of which is able to assist “additional develop its product suite, increase its operations globally, and proceed embarking on collaborations with key stakeholders transferring ahead”.
Asia’s consumer-centric digital well being ecosystem continues to develop with rising demand. It has been projected that the area’s digital well being market may attain $100 billion in worth by 2025 from $37 billion in 2020, primarily based on a report by McKinsey & Co.